Monthly Prescribing Reference3h
FDA Grants Fast Track Status to PP-01 for Cannabis Withdrawal Syndrome
The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...
Monthly Prescribing Reference6h
Probiotics Linked to Reduced Mortality in Infants Born Before 34 Weeks
HealthDay News — For infants born before 34 weeks of gestation and with a birth weight less than 1000g, probiotics used in neonatal units are associated with reduced mortality, according to a study ...
Monthly Prescribing Reference5h
Izervay Label Update Removes Limit on Treatment Duration for Geographic Atrophy
The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...
Monthly Prescribing Reference6h
Use of Secondary CVD Prevention Medications Low in Most Countries
Use of one or more classes of medications for secondary CVD prevention peaked at 43.1 percent, decreased to 31.3 percent ...
Monthly Prescribing Reference6h
Federal Judge Rules FDA, CDC Must Restore Health Websites Removed Under Trump Order
HealthDay News — A federal judge has ordered the US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) to restore access to public health websites that were ...